Soft Tissue Allografts Market Size to Cross USD 6.3 Bn Valuation by 2031 | Transparency Market Research

The global 𝐬𝐨𝐟𝐭 𝐭𝐢𝐬𝐬𝐮𝐞 𝐚𝐥𝐥𝐨𝐠𝐫𝐚𝐟𝐭𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 reached US$ 3.74 billion in 2021 and is forecasted to expand at a CAGR of 5.5% from 2022 to 2031, exceeding US$ 6.3 billion by 2031.

Soft tissue allografts are increasingly popular due to technological advancements and are driven by factors such as the aging population, growing demand in athletics, proliferation of tissue banks, and increased orthopedic surgical procedures. Companies are gearing up to introduce new soft tissue allografts products, while rising awareness, facilitated by internet penetration and social media access, is expected to boost market growth. Factors such as evolving healthcare trends, emphasis on sports, and the aging population are likely to further drive market expansion.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12275&utm_source=OpenPR&utm_campaign=MansiR

Soft tissue allografts, used in knee surgeries and other procedures, undergo a rigorous three-stage safety screening process. Comprised of bone, tendons, cartilage, and more, these allografts have been utilized successfully for over 150 years, with approximately 1 million transplants annually in the U.S.

The global demand for soft tissue allografts is rising due to increased orthopedic surgeries and dental implants, along with a growing geriatric population. However, concerns over infection risk and immune response pose potential complications, while high procedural costs and limited reimbursement may hinder market growth.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

Lattice Biologics Ltd., Zimmer Biomet, AlonSource Group, MiMedix Group, AlloSource, CONMED Corporation, Organogenesis, Inc., RTI Surgical, Inc., Osiris Therapeutics, Integra LifeSciences Corporation, Globus Medical, Inc., Straumann Holding AG, Xtant Medical, Alliqua BioMedical, Inc., C. R. Bard, Inc. (Davol, Inc.), B. Braun Melsungen AG, and Arthrex

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

Product Type

Cartilage Allografts
Hyaline Cartilage
Elastic Cartilage
Fibro Cartilage
Tendon Allografts
Achilles Tendon
Tibialis
Patellar Tendon
Hamstring
Meniscus Allografts
Dental Allografts
Free Gingival Graft
Connective Tissue Graft
Pedicle Graft
Collagen Allografts
Amniotic Allografts

Application

Orthopedic
Sports Medicine
Spine Surgeries
General Orthopedic
Reconstruction
Dentistry
Dental Sensitivity
Aesthetics
Wound Care
Others

End-user

Hospitals
Orthopedic Clinics
Dental Clinics
Ambulatory Surgical Centers
Aesthetic Centers

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In August 2022, Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatments, announced the release of CYGNUS Matrix Disks, the newest configuration of the CYGNUS family of amniotic tissue allografts. CYGNUS amniotic tissue allografts are used to cover wounds. They act as soft tissue barriers to help prevent mechanical damage. CYGNUS Matrix Disk is a flexible, multi-layer allograft that preserves the amnion layer, its intermediate/spongy layer, and the chorion layers of the amniotic sac. It also offers better handling and increased workability.

In August 2021, AlloSource introduced AlloMend Ultra-Thick Acellular Dermal Matrix (ADM), the newest addition to the AlloMend product line. The company is the largest allograft provider in the U.S. that develops cutting-edge cellular and tissue products to aid surgeons in healing patients. The thickest dermal graft offered by the company is AlloMend Ultra-Thick ADM, which is available in multiple sizes and has a thickness range of 3.0 mm to 4.0 mm. It is made using cutting-edge processing methods to guarantee that each allograft's thickness is constant throughout the entire graft. The product was created to be used in the replacement or repair of worn-out or insufficient tissue needed for difficult procedures such as superior capsule reconstruction (SCR).

𝐆𝐞𝐭 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭, 𝐈𝐧𝐬𝐭𝐚𝐧𝐭𝐥𝐲:
https://www.transparencymarketresearch.com/checkout.php?rep_id=12275<ype=S&utm_source=OpenPR&utm_campaign=MansiR

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:

North America dominated the global soft tissue allografts market in 2021. The market in the region is anticipated to grow at the fastest CAGR from 2022 to 2031 due to the presence of key players and high rate of technology adoption. Furthermore, prevalence of diabetic foot ulcers, better diabetes healthcare awareness programs, and increase in number of surgical procedures are augmenting the soft tissue allografts market share of North America.

Development of distribution channels by key players and rise in demand for collagen allografts for the treatment of severe burn injuries and breast reconstruction surgery are the factors driving the soft tissue allografts market in Asia Pacific.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Emerging trends in the soft tissue allografts market include the development of innovative processing techniques, the expansion of application areas, and the increasing focus on quality assurance and patient safety.

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

The future outlook for the soft tissue allografts market appears promising, with continued technological advancements, expanding application areas, and growing awareness driving market growth. However, market players need to navigate challenges effectively and capitalize on emerging opportunities to maintain a competitive edge.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Key market study points include understanding market dynamics, identifying growth drivers and challenges, assessing competitive landscape, and analyzing recent developments and trends. Comprehensive market research is essential for informed decision-making and strategic planning.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐃𝐨𝐰𝐧 𝐉𝐚𝐜𝐤𝐞𝐭 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/04/18/2649522/0/en/Down-Jacket-Market-is-Expected-to-Ascend-at-Around-12-8-CAGR-Exceeding-a-Valuation-of-Around-US-456-0-Billion-by-2031-TMR-Report.html

𝐌𝐞𝐫𝐜𝐚𝐩𝐭𝐚𝐧 𝐒𝐜𝐚𝐯𝐞𝐧𝐠𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/04/18/2649300/0/en/Mercaptan-Scavenger-Market-to-Expand-at-a-CAGR-of-4-6-during-Forecast-Period-2023-2031-as-per-TMR-Study.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com       
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.